Drawing for A

USPTO serial 79410369

A

Reviewed by CopyMark Law Group

Reg. 8045279Status 700Registered
Filing date
Status date
Registration date
Dec 2, 2025
Examiner
FREEMAN, BREANNA SHALEISE
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with A?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michelle P. Ciotola

Michelle P. Ciotola Cantor Colburn LLP20 Church StreetFloor 22Hartford, CT 06103

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medicinal preparations and substances, namely, vaccines; pharmaceutical and medicinal preparations and substances, namely, recombinant proteins in the nature of pharmaceutical preparations for the treatment and prevention of infectious diseasesACTIVE—
040Custom manufacture of pharmaceuticals, pharmaceutical ingredients and human vaccines, custom manufacturing of pharmaceuticals, pharmaceutical ingredients and human vaccines.ACTIVE—
042Research and development in the field of human vaccines; high-throughput vaccine engineering services; medical and scientific research services in the field of recombinant protein platform technologies for new human vaccines; product research and development and scientific research, all in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients and human vaccines; medical and scientific research in the field of clinical trial studies on new vaccine candidates for othersACTIVE—
044Medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, diagnostic, prophylactic and therapeutic properties of vaccines; on-line health information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, diagnostic, prophylactic and therapeutic properties of vaccinesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2026LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jul 9, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 18, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 18, 2026FIMPFINAL DISPOSITION PROCESSED—
May 7, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 20, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 20, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 2, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 2, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 2, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 14, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 14, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 8, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 18, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Sep 18, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 18, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 18, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 16, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 16, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2025RFNTREFUSAL PROCESSED BY IB—
Apr 15, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 15, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 10, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 9, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 7, 2025DOCKASSIGNED TO EXAMINER—
Nov 24, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 24, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 21, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance